Concord Net Cash Flow from Operations from 2010 to 2024
| CCM Stock | USD 0.58 0.05 7.94% |
Check Concord Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Concord main balance sheet or income statement drivers, such as Interest Expense of 145.3 M, Selling General Administrative of 375.7 M or Total Revenue of 431.6 M, as well as many exotic indicators such as Price To Sales Ratio of 1.14, Dividend Yield of 0.14 or Days Sales Outstanding of 232. Concord financial statements analysis is a perfect complement when working with Concord Medical Valuation or Volatility modules.
Concord | Net Cash Flow from Operations |
About Concord Medical Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Concord Medical income statement, its balance sheet, and the statement of cash flows. Concord Medical investors use historical funamental indicators, such as Concord Medical's Net Cash Flow from Operations, to determine how well the company is positioned to perform in the future. Although Concord Medical investors may use each financial statement separately, they are all related. The changes in Concord Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Concord Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Concord Medical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Concord Medical. Please read more on our technical analysis and fundamental analysis pages.
Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the Peoples Republic of China. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, the Peoples Republic of China. Concord Medical operates under Medical Care Facilities classification in the United States and is traded on New York Stock Exchange. It employs 972 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Concord Medical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Concord Medical's short interest history, or implied volatility extrapolated from Concord Medical options trading.
Pair Trading with Concord Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Concord Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Concord Medical will appreciate offsetting losses from the drop in the long position's value.Moving together with Concord Stock
| 0.61 | EMBC | Embecta Corp Financial Report 10th of May 2024 | PairCorr |
Moving against Concord Stock
| 0.86 | ELMD | Electromed | PairCorr |
| 0.82 | HIMS | Hims Hers Health Financial Report 13th of May 2024 | PairCorr |
| 0.81 | ALC | Alcon AG Financial Report 14th of May 2024 | PairCorr |
| 0.79 | BAX | Baxter International Financial Report 25th of April 2024 | PairCorr |
| 0.69 | EOLS | Evolus Inc Financial Report 14th of May 2024 | PairCorr |
The ability to find closely correlated positions to Concord Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Concord Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Concord Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Concord Medical Services to buy it.
The correlation of Concord Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Concord Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Concord Medical Services moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Concord Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Concord Medical Correlation against competitors. Note that the Concord Medical Services information on this page should be used as a complementary analysis to other Concord Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for Concord Stock analysis
When running Concord Medical's price analysis, check to measure Concord Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Concord Medical is operating at the current time. Most of Concord Medical's value examination focuses on studying past and present price action to predict the probability of Concord Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Concord Medical's price. Additionally, you may evaluate how the addition of Concord Medical to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |
Is Concord Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.48) | Revenue Per Share 14.017 | Quarterly Revenue Growth 0.972 | Return On Assets (0.05) | Return On Equity (0.31) |
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.